pp60c-src activation in lung adenocarcinoma

European Journal of Cancer

Volumn 39, Issue 10, 2003, Pages 1447-1455

  Masaki, T ^a   Igarashi, K ^b   Tokuda, M ^a   Yukimasa, S ^a   Han, F ^a   Jin, Y J ^a   Li, J Q ^a   Yoneyama, H ^a   Uchida, N ^a   Fujita, J ^a   Yoshiji, H ^c   Watanabe, S ^a   Kurokohchi, K ^a   Kuriyama, S ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b TOKYO TEISHIN HOSPITAL   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Kinase activity; Lung cancer; Src

Indexed keywords

GENE PRODUCT; PHOSPHOPEPTIDE; PROTEIN KINASE P60; TYROSINE; PROTEIN TYROSINE KINASE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER TISSUE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MALE; ONCOGENE SRC; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTO ONCOGENE; WESTERN BLOTTING; ADENOCARCINOMA; CELL CULTURE; ENZYMOLOGY; LUNG TUMOR; METABOLISM; MIDDLE AGED; POLYACRYLAMIDE GEL ELECTROPHORESIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS PP60(C-SRC); TUMOR CELLS, CULTURED;

EID: 0037784223     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00276-4     Document Type: Article

References (37)

1. c-src kinase by middle T antigen binding or dephosphorylation. EMBO J. 5:1985;1471-1477.
2. c-src. Cell. 49:1987;75-82.
3. c-src mutated in the carboxyl-terminal regulatory domain. Cell. 49:1987;83-91.
4. Reynolds A.B., Rosel D.J., Kanner S.B., Parsons J.T. Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol. Cell Biol. 9:1989;629-638.
5. Bolen J.B. Nonreceptor tyrosine kinase. Oncogene. 8:1993;2025-2031.
6. Thoumas S.M., Brugge J.S. Cellular functions regulated by Src family kinase. Annu. Rev. Cell Dev. Biol. 13:1997;513-609.
7. Bishop J.M. Molecular themes in oncogenesis. Cell. 64:1991;235-248.
8. Guy C.T., Muthuswamy S.K., Cardiff R.D., Soriano P., Muller W.J. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumor in transgenic mice. Genes Dev. 8:1994;23-32.
9. c-src in human small cell and non-small cell lung carcinoma. Eur. J. Cancer. 28:1992;372-377.
10. c-src in 60 different cell lines derived from human tumors. Cancer Biochem. Biophys. 14:1994;171-175.
11. c-src activation in hepatocellular carcinoma of humans and LEC rats. Hepatology. 27:1998;1257-1264.
12. c-src activity in colorectal cancer. Cancer. 92:2000;61-70.
13. Ottenhoff Kalff A.E., Rijksen G., Van-beurden E.A., Hennipman A., Michels A.A., Steal G.E. Characterization of protein kinase from human breast cancer. involvement of the c-src oncogene product Cancer Res. 52:1992;4773-4778.
14. c-src activation in human colon carcinoma. J. Clin. Invest. 83:1989;2025-2033.
15. Talamonti M.S., Roh M.S., Curley S.A., Gallick G.E. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J. Clin. Invest. 91:1993;53-60.
16. Lutz M.P., Esser I.B., Flossmann-Kast B.B.et al. Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem. Biophys. Res. Commun. 243:1998;503-508.
17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
19. Towbin H., Stadhelin T., Gordon J. Electrophoretic transfer of protein from polyacrylamide gel to nitrocellulose sheets. procedure and some applications Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
20. Eckhart W., Hutchinson M.A., Hunter T. An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell. 18:1979;925-934.
21. c-src associated with polyoma middle tumor antigen. Mol. Cell Biol. 6:1986;1562-1570.
22. Hunter T., Sefton B.M. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA. 77:1980;1311-1315.
23. c-src. implication for regulation Science. 231:1986;1431-1433.
24. c-src. Nature. 351:1991;69-72.
25. Collett M.S., Erikson E., Erikson R.L. Structural analysis of the avian sarcoma virus transforming protein. sites of phosphorylation J. Viol. 29:1999;770-781.
26. c-src accompany differentiation of neurous from rat embryo striatum. Mol. Cell. Biol. 7:1987;1830-1840.
27. c-src to the cytoskeleton during platelet aggregation. EMBO J. 11:1992;855-861.
28. Irby R.B., Mao W., Coppola D.et al. Activating SRC mutation in a subset of advanced human colon cancers. NatGenet. 21:1999;187-190.
29. Laghi L., Bianchi P., Orbetegli O., Gennari L., Roncalli M., Malesci A. Lack of mutation at codon 531 of Src in advanced colorectal cancers from Italian patients. Br. J. Cancer. 84:2001;196-198.
30. Masaki T., Okada M., Tokuda M.et al. Reduced C-terminal src kinase (Csk) activities in hepatocellular carcinoma. Hepatology. 29:1999;379-384.
31. Takahashi Y., Kitadai Y., Bucava C.D., Cleary K.R., Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55:1995;3964-3968.
32. Suzuki K., Hayashi N., Miyamoto Y.et al. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res. 56:1996;3004-3009.
33. Yuan A., Yu C.J., Luh K.T.et al. Quantification of VEGF mRNA expression in non-small cell lung cancer using a real-time quantitative reverse transcription-PCR assay and a comparison with quantitative competitive reverse transcription-PCR. Lab. Invest. 80:2000;1671-1680.
34. Senger D.R., Perruzzi C.A., Feder J., Dvorak H.F. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 46:1986;5629-5632.
35. Yuan A., Yu C.J., Chen W.J.et al. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int. J. Cancer. 89:2000;475-483.
36. Ellis L.M., Staley C.A., Liu W.et al. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-Src. J. Biol. Chem. 273:1998;1052-1057.
37. Ellis L.M., Staley C.A., Liu W.et al. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-Src. Surgery. 122:1997;501-507.